Search Results

You are looking at 41 - 50 of 56 items for :

  • Hashimoto���s thyroiditis x
  • Refine by Access: All content x
Clear All
Open access

Xichang Wang, Xiaochun Teng, Chenyan Li, Yushu Li, Jing Li, Weiping Teng, Zhongyan Shan, and Yaxin Lai

hyperthyroidism, the most common of which is Graves’ disease (GD); other types include toxic multinodular goiter (TMNG), toxic thyroid adenoma (TA) and Hashimoto’s hyperthyroidism. According to the findings of the Thyroid Disease, Iodine Nutrition and Disease

Open access

Chiara Mele, Maria Teresa Samà, Alessandro Angelo Bisoffi, Marina Caputo, Valentina Bullara, Stefania Mai, Gillian Elisabeth Walker, Flavia Prodam, Paolo Marzullo, Gianluca Aimaretti, and Loredana Pagano

expression in normal thyroid tissue ( 58 ). On the contrary, Karaoglu et al . demonstrated obestatin expression in healthy thyroid, Hashimoto thyroiditis and PTC without evident differences in the intensity of reaction ( 12 ). In a recent study, obestatin

Open access

Enrique Soto-Pedre, Paul J Newey, John S Bevan, and Graham P Leese

of hyperprolactinemia in patients with Hashimoto’s thyroiditis . Endocrine Journal 1997 44 89 – 94 . ( doi:10.1507/endocrj.44.89 ) 9152619 10.1507/endocrj.44.89 22 Harirchian MH Sahraian MA Shirani A. Serum prolactin level in

Open access

Marek Niedziela

goitrous form of AIT is termed as Hashimoto’s disease), but its pathogenesis results from destruction of the gland with excessive release of prestored thyroid hormones. That these two functionally opposite states, GD and AIT, can develop in the same

Open access

Ningning Gong, Cuixia Gao, Xuedi Chen, Yu Wang, and Limin Tian

hashimoto thyroiditis . Abstract SUN-455 presented at the Endocrine Society's 95th Annual Meeting and Expo, June 15–18, 2013, San Francisco. (available at: ) 44 Guzel S Seven A

Open access

Irfan Vardarli, Manuel Weber, Frank Weidemann, Dagmar Führer, Ken Herrmann, and Rainer Görges

Duan H Wahl K Pirich C Antoni A Kommata S Kletter K Dudczak R Karanikas G Willheim M T lymphocyte cytokine production patterns in Hashimoto patients with elevated calcitonin levels and their relationship to tumor initiation

Open access

Lei Hu, Xiao Liu, Chong Pei, Li Xie, and Nianan He

– 1165 . ( ) 30 Wang D Du LY Sun JW Hou XJ Wang H Wu JQ Zhou XL Evaluation of thyroid nodules with coexistent Hashimoto’s thyroiditis according to various ultrasound-based risk stratification

Open access

Mengxue Yang, Bowen Sun, Jianhui Li, Bo Yang, Jie Xu, Xue Zhou, Jie Yu, Xuan Zhang, Qun Zhang, Shan Zhou, and Xiaohua Sun

autoimmune thyroiditis diseases varies according to ethnicity ( 4 ). GD has a prevalence rate of approximately 1.2% (0.5% overt and 0.7% subclinical) ( 3 ) and an annual incidence of 20–50 cases per 100,000 persons in the USA ( 5 ), and the incidence among

Open access

Susana Pastor, Abdelmounaim Akdi, Eddy R González, Juan Castell, Josefina Biarnés, Ricard Marcos, and Antonia Velázquez

:10.1210/jc.2004-1336 ). 43 Ban Y Tozaki T Taniyama M Tomita M Ban Y . Association of a thyroglobulin gene polymorphism with Hashimoto's thyroiditis in the Japanese population . Clinical Endocrinology 2004 61 263 – 268 . ( doi:10

Open access

Xuechao Jiang, Yonghui Wang, Xiaoying Li, Leqi He, Qian Yang, Wei Wang, Jun Liu, and Bingbing Zha

, and autoimmune thyroid disease (AITD) ( 11 , 12 , 13 , 14 , 15 ). AITD, which includes GD and Hashimoto’s thyroiditis, is caused by an immune response to self-thyroid antigens ( 16 ). Single-nucleotide polymorphisms (SNPs) in the promoter of SAS